Research Article
Late Onset of Antiretroviral Therapy in Adults Living with HIV in an Urban Area in Brazil: Prevalence and Risk Factors
Table 3
Univariate and multivariate analysis of factors associated with late
of antiretroviral therapy among 1,141 people living with HIV, 2009-2012.
| Variables | OR (95%CI) | p-value | Adjusted | p-value | (95%CI) |
| Age (years) | 1.0 (1.0-1.0) | 0.119 | 1.0 (1.0-1.0) | 0.850 | Skin color | | Brown | 1.7 (1.2-2.4) | <0.001 | 1.4 (1.0-2.0) | 0.082 | Black | 1.2 (0.7-2.3) | 0.299 | 1.2 (0.6-2.5) | 0.621 | Unknown | 1.1 (0.7-1.8) | 0.383 | 0.7 (0.4-1.2) | 0.173 | White | 1 | | 1 | | Education level | | Unknown | 2.4 (1.7-3.3) | <0.001 | 2.0 (1.4-2.5) | <0.001 | ≤ 8 years | 1.9 (1.5-2.5) | <0.001 | 1.7 (1.2-2.5) | 0.001 | > 8 years | 1 | | 1 | | Place of | | | | | Others | 1.9 (1.5-2.4) | < 0.001 | 1.4 (1.1-2.0) | 0.003 | Goiânia | 1 | 1 | Marital | | | | | Single/separated/widowed | 1.1 (0.8-1.4) | 0.341 | - | | Married/consensual union | 1 | Sex/Sexual behavior | | Female | 2.0 (1.4-2.7) | < 0.001 | 1.7 (1.1-2.5) | 0.016 | Heterosexual male | 1.9 (1.3-2.6) | < 0.001 | 1.4 (1.0-2.5) | 0.030 | Male/Unknown sexual behavior | 3.3 (2.3-4.8) | < 0.001 | 2.5 (1.7-5.0) | < 0.001 | Homosexual/Bisexual male | 1 | | 1 | | Injecting drug use | | Yes | 5.6 (1.4-36.8) | 0.010 | 3.3 (0.7-10.0) | 0.133 | No/unknown | 1 | 1 | Viral load (copies/cm3) | | | | | ≥ 100,000 | 4.4 (3.4-5.8) | < 0.001 | 5.0 (3.3- 10.0) | < 0.001 | < 100,000 | 1 | 1 | Hepatitis B virus | | Yes | 2.0 (1.0-4.2) | 0.039 | 2.5 (1.25-5.0) | 0.013 | No/unknown | 1 | 1 | Hepatitis C virus | | Yes | 1.2 (0.5-3.1) | 0.439 | - | | No/unknown | 1 | Pharmacological | | | | | NRTI + PI | 1.5 (1.1-1.9) | 0.002 | 1.4 (1.0-1.7) | 0.041 | NRTI + NNRTI | 1 | 1 |
|
|
initiation defined as baseline CD4+ cell count < 200 cells/cm 3 or baseline AIDS-defining illness. = odds ratio; 95%CI = 95% confidence interval. information: n=15. marital: n=29. : nucleoside reverse transcriptase inhibitors. Regression model adjusted for age, skin color, education level, place of residence, sex/sexual behavior, injecting drug use, viral load, hepatitis B virus, and pharmacological drugs group. NNRTI: nonnucleoside reverse transcriptase inhibitor; PI: protease inhibitor. |